Pulse Biosciences, Inc. (PLSE) Reports Q2 Loss of $0.54

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Pulse Biosciences, Inc. (PLSE) Reports Q2 Loss of $0.54

Pulse Biosciences Quarterly Investor Conference Call

July 31, 2018 4:00 PM EDT

Conference call today at 1:30 p.m. PDT / 4:30 p.m. EDT

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a clinical stage electroceutical company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, today reported recent corporate developments and financial results for the three- and six-month periods ended June 30, 2018.

Recent Developments

Announced treatment of first subjects in a study to evaluate the safety and efficacy of novel Nano-Pulse Stimulation for the treatment of Sebaceous Hyperplasia (SH), a common but difficult-to-treat... More